What Researchers Did
Researchers conducted a literature review of articles published between 2018 and 2021 in PubMed and Scopus to identify molecular targets and therapies acting on angiogenesis for diabetic foot ulcer (DFU) repair.
What They Found
The review identified growth factors, microRNAs, and signaling pathways as promising molecular targets for enhancing angiogenesis in diabetic foot ulcers. Explored therapies included negative pressure wound therapy, hyperbaric oxygen therapy, and nanomedicine, all showing potential in promoting DFU healing by targeting angiogenesis.
What This Means for Canadian Patients
Canadian patients with diabetic foot ulcers, a common and severe complication of diabetes, may benefit from future innovative therapies that target angiogenesis to improve wound healing. These emerging approaches, including nanomedicine and hyperbaric oxygen therapy, could offer new options beyond current inadequate treatments, potentially reducing morbidity and healthcare costs.
Canadian Relevance
This review article has no direct Canadian connection as it was not conducted in Canada or by Canadian researchers.
Study Limitations
A limitation of this review is its focus on articles published only between 2018 and 2021, potentially excluding earlier relevant research or very recent developments.